AU;Current Trials
  • Home
  • Clinical Trials
  • Alopecia Areata Studies Kapiti 102

Alopecia Areata Studies

Kapiti

Join a clinical trial that explores potential new treatments for people suffering from Alopecia Areata

Description

What to expect

Study details

Ages

Open Ages

Duration

Varies

Compensation

You will be well compensated for any study related costs

Eligibility Criteria

You may qualify if you:

  • Have a clinical diagnosis for Alopecia Areata
  • Are in generally good health
  • Can visit the Kapiti Momentum clinic for appointments 

Other eligibility criteria apply. A member of our team will check if this study is a good fit for you.

Locations

Kapiti

Description

Alopecia Areata is an autoimmune condition where the body mistakenly attacks hair follicles, causing hair loss on the scalp or body. It can appear as small patches or, in more severe cases, result in total loss of scalp and/or body hair. While not physically harmful, it can have a significant impact on a person's self-esteem and quality of life. Living with alopecia areata can sometimes lead to feelings of anxiety and depression, showing why more effective treatment options are needed to support people in living with confidence each day. 

Current treatments for Alopecia Areata, such as corticosteroids, immunotherapy and newer medications, can sometimes help regrow hair, but they are not effective for everyone, and relapses are common.  

What to expect

Momentum Clinical Research conducts research studies that test new potential treatments that aim to protect people from Alopecia Areata. Register your interest now to find out if you are eligible to participate in this study and help develop potential new treatment options.

All study treatments are free of charge and participants are paid for any study related costs.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.

Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

New Zealand locations

WellingtonTaurangaHawke's BayKapitiPalmerston NorthLower HuttDunedinPukekohe AucklandPCRN Clinical Trial Sites

Australian locations

Fortitude Valley BrisbaneTaringa BrisbaneWellers Hill BrisbaneSunshine MelbourneDarlinghurst SydneySt Leonards Sydney

2025 © Momentum Clinical Research

Privacy Policy